Biotricity, Inc. Common Stock
BTCY
BTCY was delisted on the 2nd of August, 2024.
29 hedge funds and large institutions have $1.19M invested in Biotricity, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 4 closing their positions.
222% more capital inflows, than outflows
Capital inflows: $103K | Capital outflows: $32.1K
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
0.12% more ownership
Funds ownership: 5.1% → 5.22% (+0.12%)
0% more funds holding
Funds holding: 29 → 29 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AE Wealth Management
Topeka,
Kansas
|
+$46.1K |
| 2 |
Jane Street
New York
|
+$16.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$13.6K |
| 4 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
+$11.3K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$8.95K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$19K |
| 2 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$9K |
| 3 |
SFCL
Strengthening Families & Communities LLC
Boston,
Massachusetts
|
-$2K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$818 |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$641 |
BTCY Hedge Fund Activity: Q4 2022 in Review
29 of the 6,241 institutional investors tracked by Wall St. Rank reported a position in Biotricity, Inc. Common Stock (BTCY) for Q4 2022, worth a combined $1.19M — down 42% from $2.05M a quarter earlier.
Fund positioning in BTCY was balanced in Q4 2022: 4 funds opened new positions, 4 closed out, 7 added to existing stakes and 4 trimmed.
The largest buyer was AE Wealth Management, opening a new position worth an estimated $46.1K. The largest seller was Citadel Advisors, exiting entirely with an estimated $19K sold.
- 29 institutional investors held Biotricity, Inc. Common Stock (BTCY) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $1.19M of Biotricity, Inc. Common Stock stock for Q4 2022, down 42% quarter-over-quarter.
- 4 funds opened new Biotricity, Inc. Common Stock positions in Q4 2022 and 4 closed out, a net change of 0 holders.
- The largest Biotricity, Inc. Common Stock buyer in Q4 2022 was AE Wealth Management, an estimated $46.1K added.
- The largest Biotricity, Inc. Common Stock seller in Q4 2022 was Citadel Advisors, an estimated $19K sold.
Based on aggregated 13F filings for Q4 2022.